ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2879

Genome-Wide Pathway Analysis Reveals That VEGF Genetic Pathway Is Associated with Oral Ulcers in Systemic Lupus Erythematosus

Antonio Julià1, Patricia Carreira2, Ricardo Blanco3, Victor Martinez Taboada4, Luis Carreño5, Jose Javier Perez Venegas6, Alejandro Olivé7, Jose Luis Andreu8, Maria Ángeles Aguirre Zamorano9, Paloma Vela10, Joan Miquel Nolla11, José Luis Marenco de la Fuente12, Antonio Zea13, JM Pego-Reigosa14, Mercedes Freire15, Elvira Diez Alvarez16, Adrìa Aterido1, Arnald Alonso1, Maria López-Lasanta17, Mireia López18, Raül Tortosa1, Sara Marsal19 and Antonio Fernandez-Nebro20, 1Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 2Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 3Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 4Hospital Marqués de Valdecilla., Santander, Spain, 5Rheumatology, HGU Gregorio Marañón, Madrid, Spain, 6Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, 7Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, 8Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 9Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 10Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 11Rheumatology, Bellvitge University Hospital, Barcelona, Spain, 12Rheumatology, Hospital de Valme, Seville, Spain, 13Hospital Ramón y Cajal. Madrid, Madrid, Spain, 14Rheumatology Section, Hospital de Meixoeiro, Pontevedra, Spain, Vigo, Spain, 15Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 16Rheumatology, Hospital de León, León, Spain, 17Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 18Servicio de Reumatología, Hospital Universitario Vall d´Hebron, Barcelona, Spain, 19Rheumatology Research Unit, Vall d'Hebron Hospital, Barcelona, Spain, 20Rheumatology, Hospital Universitario Carlos Haya, Malaga, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Genetic architecture, GWAS, phenotypes, systemic lupus erythematosus (SLE) and ulcers

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a genetically complex rheumatic disease with heterogeneous clinical manifestations. Recent studies have suggested the existence of a genetic basis for the diverse SLE clinical phenotypes. Also, there is increasing evidence indicating that a substantial part of the genetic variation associated with complex diseases could be explained by small-effect genes from common genetic pathways. The objective of the present study was to identify new genetic variation associated with SLE phenotypes using a genome-wide association study at the pathway level.

Methods:  A total of 598,258 SNPs were genotyped in a discovery cohort of n=482 SLE patients of southern European ancestry using the Illumina platform Quad610. After quality control analysis, including ancestry estimation using principal-component analysis, genome-wide pathway analysis was performed. A total of 14 clinically relevant SLE phenotypes were tested for association in n>700 reference genetic pathways. Significantly associated pathways (corrected P-value < 0.05) were subsequently tested for validation in an independent cohort of n=425 SLE patients from the same ancestry. Both discovery and validation cohort patients were Caucasian European and from Spanish origin, and were recruited by n=15 rheumatology departments from Spanish university hospitals. The validated genetic pathways were functionally characterized using in silico analysis on cell types of relevance in SLE pathogenesis.

Results:  In the discovery stage, two genetic pathways were significantly associated with the presence of oral ulcers and antinuclear antibodies in SLE (PFDR<0.05). In the replication stage, we validated the association between oral ulcers and the vascular endothelial growth factor (VEGF) genetic pathway (P=1.3e-2). Analyzing the transcriptional effect of the topical immunotherapies used for the treatment of oral ulcers in SLE, we found a significant differential expression of VEGF pathway genes (P<0.05).

Conclusion:  In this work we have performed the first genome-wide association study for clinically relevant SLE phenotype using a pathway-based approach. With this new approach, we have identified and validated the association of VEGF genetic pathway with oral ulcers in SLE. These findings represent an important step towards the characterization of the genetic basis of phenotype heterogeneity in SLE.


Disclosure: A. Julià, None; P. Carreira, None; R. Blanco, None; V. Martinez Taboada, None; L. Carreño, None; J. J. Perez Venegas, None; A. Olivé, None; J. L. Andreu, None; M. Á. Aguirre Zamorano, None; P. Vela, None; J. M. Nolla, None; J. L. Marenco de la Fuente, None; A. Zea, None; J. Pego-Reigosa, None; M. Freire, None; E. Diez Alvarez, None; A. Aterido, None; A. Alonso, None; M. López-Lasanta, None; M. López, None; R. Tortosa, None; S. Marsal, None; A. Fernandez-Nebro, None.

To cite this abstract in AMA style:

Julià A, Carreira P, Blanco R, Martinez Taboada V, Carreño L, Perez Venegas JJ, Olivé A, Andreu JL, Aguirre Zamorano MÁ, Vela P, Nolla JM, Marenco de la Fuente JL, Zea A, Pego-Reigosa J, Freire M, Diez Alvarez E, Aterido A, Alonso A, López-Lasanta M, López M, Tortosa R, Marsal S, Fernandez-Nebro A. Genome-Wide Pathway Analysis Reveals That VEGF Genetic Pathway Is Associated with Oral Ulcers in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genome-wide-pathway-analysis-reveals-that-vegf-genetic-pathway-is-associated-with-oral-ulcers-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-pathway-analysis-reveals-that-vegf-genetic-pathway-is-associated-with-oral-ulcers-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology